Literature DB >> 27429716

Assembly and release of infectious hepatitis C virus involving unusual organization of the secretory pathway.

Miriam Triyatni1, Edward A Berger1, Bertrand Saunier1.   

Abstract

AIM: To determine if calnexin (CANX), RAB1 and alpha-tubulin were involved in the production of hepatitis C virus (HCV) particles by baby hamster kidney-West Nile virus (BHK-WNV) cells.
METHODS: Using a siRNA-based approach complemented with immuno-fluorescence confocal microscope and Western blot studies, we examined the roles of CANX, RAB1 and alpha-tubulin in the production of HCV particles by permissive BHK-WNV cells expressing HCV structural proteins or the full-length genome of HCV genotype 1a. Immuno-fluorescence studies in producer cells were performed with monoclonal antibodies against HCV structural proteins, as well as immunoglobulin from the serum of a patient recently cured from an HCV infection of same genotype. The cellular compartment stained by the serum immunoglobulin was also observed in thin section transmission electron microscopy. These findings were compared with the JFH-1 strain/Huh-7.5 cell model.
RESULTS: We found that CANX was necessary for the production of HCV particles by BHK-WNV cells. This process involved the recruitment of a subset of HCV proteins, detected by immunoglobulin of an HCV-cured patient, in a compartment of rearranged membranes bypassing the endoplasmic reticulum-Golgi intermediary compartment and surrounded by mitochondria. It also involved the maturation of N-linked glycans on HCV envelope proteins, which was required for assembly and/or secretion of HCV particles. The formation of this specialized compartment required RAB1; upon expression of HCV structural genes, this compartment developed large vesicles with viral particles. RAB1 and alpha-tubulin were required for the release of HCV particles. These cellular factors were also involved in the production of HCVcc in the JFH-1 strain/Huh-7.5 cell system, which involves HCV RNA replication. The secretion of HCV particles by BHK-WNV cells presents similarities with a pathway involving caspase-1; a caspase-1 inhibitor was found to suppress the production of HCV particles from a full-length genome.
CONCLUSION: Prior activity of the WNV subgenomic replicon in BHK-21 cells promoted re-wiring of host factors for the assembly and release of infectious HCV in a caspase-1-dependent mechanism.

Entities:  

Keywords:  Flavivirus replicon; Hepatitis C virus; Host cellular factors; Membrane rearrangements; Virus assembly and secretion

Year:  2016        PMID: 27429716      PMCID: PMC4937168          DOI: 10.4254/wjh.v8.i19.796

Source DB:  PubMed          Journal:  World J Hepatol


  83 in total

1.  Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

Authors:  Budhaditya Mazumdar; Arup Banerjee; Keith Meyer; Ranjit Ray
Journal:  Hepatology       Date:  2011-07-25       Impact factor: 17.425

Review 2.  Assembly of infectious hepatitis C virus particles.

Authors:  Ralf Bartenschlager; Francois Penin; Volker Lohmann; Patrice André
Journal:  Trends Microbiol       Date:  2010-12-14       Impact factor: 17.079

3.  Virion-independent transfer of replication-competent hepatitis C virus RNA between permissive cells.

Authors:  Andrea Longatti; Bryan Boyd; Francis V Chisari
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

4.  Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.

Authors:  J Dubuisson; C M Rice
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

5.  Association of hepatitis C virus envelope proteins with exosomes.

Authors:  Francesca Masciopinto; Cinzia Giovani; Susanna Campagnoli; Luisa Galli-Stampino; Piero Colombatto; Maurizia Brunetto; T S Benedict Yen; Michael Houghton; Piero Pileri; Sergio Abrignani
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

6.  Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.

Authors:  Miriam Triyatni; Bertrand Saunier; Padma Maruvada; Anthony R Davis; Luca Ulianich; Theo Heller; Arvind Patel; Leonard D Kohn; T Jake Liang
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Role for TBC1D20 and Rab1 in hepatitis C virus replication via interaction with lipid droplet-bound nonstructural protein 5A.

Authors:  Inbar Nevo-Yassaf; Yakey Yaffe; Meital Asher; Orly Ravid; Sharon Eizenberg; Yoav I Henis; Yaakov Nahmias; Koret Hirschberg; Ella H Sklan
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

8.  Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90.

Authors:  Terence N Bukong; Fatemeh Momen-Heravi; Karen Kodys; Shashi Bala; Gyongyi Szabo
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

9.  Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.

Authors:  Christina Sølund; Henrik Krarup; Santseharay Ramirez; Peter Thielsen; Birgit T Røge; Suzanne Lunding; Toke S Barfod; Lone G Madsen; Britta Tarp; Peer B Christensen; Jan Gerstoft; Alex L Laursen; Jens Bukh; Nina Weis
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 10.  Virus factories: biogenesis and structural design.

Authors:  Isabel Fernández de Castro; Luca Volonté; Cristina Risco
Journal:  Cell Microbiol       Date:  2012-10-04       Impact factor: 3.715

View more
  2 in total

Review 1.  Role of Host Cell Secretory Machinery in Zika Virus Life Cycle.

Authors:  Garrett Sager; Samuel Gabaglio; Elizabeth Sztul; George A Belov
Journal:  Viruses       Date:  2018-10-15       Impact factor: 5.048

2.  The envelope protein of Zika virus interacts with apolipoprotein E early in the infectious cycle and this interaction is conserved on the secreted viral particles.

Authors:  Yannick Tréguier; Jade Cochard; Julien Burlaud-Gaillard; Roxane Lemoine; Philippe Chouteau; Philippe Roingeard; Jean-Christophe Meunier; Marianne Maquart
Journal:  Virol J       Date:  2022-07-28       Impact factor: 5.913

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.